A carregar...
Curing Ph(+) ALL: assessing the relative contributions of chemotherapy, TKIs, and allogeneic stem cell transplant
The understanding and treatment of Philadelphia chromosome-positive (Ph(+)) acute lymphoblastic leukemia have changed rapidly in the past 10 years. The outcome is equally as good as for Ph(−) disease, and with targeted tyrosine kinase inhibitor therapies in addition to chemotherapy, the novel immuno...
Na minha lista:
| Publicado no: | Hematology Am Soc Hematol Educ Program |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Hematology
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6913432/ https://ncbi.nlm.nih.gov/pubmed/31808885 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/hematology.2019000010 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|